KWILP
OCUL icon

Kiwi Wealth Investments Limited Partnership’s Ocular Therapeutix OCUL Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-54,741
Closed -$776K – 262
2021
Q2 		$776K Buy
+54,741
New +$832K 0.04% 211

Other funds holding OCUL

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's OCUL Position: Q3 2021 in Review

Kiwi Wealth Investments Limited Partnership sold out of Ocular Therapeutix (OCUL) in Q3 2021, closing a stake of 54,741 shares — an estimated $776K sold.

Kiwi Wealth Investments Limited Partnership first reported a position in OCUL in Q2 2021 and held it in 1 quarter. The position peaked at $776K in Q2 2021. 141 funds tracked by Wall St. Rank hold OCUL as of Q3 2021.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Ocular Therapeutix position as of Q3 2021 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 54,741 Ocular Therapeutix shares in Q3 2021, an estimated $776K.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Ocular Therapeutix in Q2 2021 and held it in 1 quarter.
  • Kiwi Wealth Investments Limited Partnership's Ocular Therapeutix position peaked at $776K in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2021.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2021, filed 16 Nov 2021.